1) Alaspaa AO, Kuisma MJ, Hoppu K, et al: Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med 2005; 45:207-12. 2) Anderson HR, Dick B, & Macnair RS: An investigation of 140 deaths associated with volatile substance abuse in the United Kingdom (1971-1981). Human Toxicol 1982; 1:207-221. 3) Anderson RJ, Garza HR, & Garriott JC: Intravenous propylhexedrine (Benzedrex(R)) abuse and sudden death. Am J Med 1979; 67:15-20. 4) Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347. 5) Baselt RC: Disposition of Toxic Drugs and Chemicals in Man, 2nd ed, Biomedical Publications, Davis, CA, 1982. 6) Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308. 7) Budavari S: The Merck Index, 11th ed, Merck & Company, Inc. Rahway, NJ, 1989. 8) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212. 9) Cameron J, Waugh L, & Loadsman T: Possible association of pulmonary hypertension with an anorectic drug. Med J Aust 1984; 140:595-597. 10) Caravati EM, Knight HH, & Linscott MS: Esophageal laceration and charcoal mediastinum complicating gastric lavage. J Emerg Med 2001; 20:273-276. 11) Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012. 12) Chyka PA, Seger D, Krenzelok EP, et al: Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43(2):61-87. 13) Covey DC, Nossaman BD, & Albright AA: Ischemic injury of the hand from intra-arterial propylhexedrine injection. J Hand Surg 1988; 13a:58-61. 14) Croft CH, Firth BG, & Hillis LD: Propylhexedrine-induced left ventricular dysfunction. Ann Intern Med 1982; 97:560-561. 15) Croft CH, Firth RG, & Hillis LD: Propylhexedrine induced left ventricular dysfunction. Ann Intern Med 1982a; 97:560-561. 16) Dagnone D, Matsui D, & Rieder MJ: Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers. Pediatr Emerg Care 2002; 18:19-21. 17) DiMaio VJM & Garriott JC: Intravenous abuse of propylhexedrine. J Forensic Sci 1977; 22:152-158. 18) Elliot CG, Colby TV, & Kelly TM: Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674. 19) FDA: Poison treatment drug product for over-the-counter human use; tentative final monograph. FDA: Fed Register 1985; 50:2244-2262. 20) Fernandez Julia P & Francis EM: Propylhexedrine: a vintage drug of abuse, rediscovered. J Psychoactive Drugs 2012; 44(3):277-279. 21) Fornazzari L, Carlen PL, & Kapur BM: Intravenous abuse of propylhexedrine (Benzedrex(R)) and the risk of brainstem dysfunction in young adults. Can J Neurol 1986; 13:337-339. 22) Garriott JC: Propylhexedrine-a new dangerous drug?. Clin Toxicol 1975; 8:665-666. 23) Gilman AG, Rall TW, & Nies AS: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, Pergamon Press, New York, NY, 1990. 24) Golej J, Boigner H, Burda G, et al: Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49:315-318. 25) Graff GR, Stark J, & Berkenbosch JW: Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959-961. 26) Guenther Skokan E, Junkins EP, & Corneli HM: Taste test: children rate flavoring agents used with activated charcoal. Arch Pediatr Adolesc Med 2001; 155:683-686. 27) Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486. 28) Hamilton LH: Nasal decongestant effect of propylhexedrine. Ann Otol 1982; 91:106-111. 29) Harris CR & Filandrinos D: Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470-1473. 30) JEF Reynolds : Martindale: The Extra Pharmacopoeia (electronic version). The Pharmaceutical Press. London, UK (Internet Version). Edition expires 1990; provided by Truven Health Analytics Inc., Greenwood Village, CO. 31) JEF Reynolds : Martindale: The Extra Pharmacopoeia (electronic version). The Pharmaceutical Press. London, UK (Internet Version). Edition expires 2000; provided by Truven Health Analytics Inc., Greenwood Village, CO. 32) Johnson J, Johnson DAW, & Robins AJ: Propylhexedrine chewing and psychosis (letter). Br Med J 1972; 3:529-530. 33) Kew MC, Hopp M, & Rothberg A: Fatal heat-stroke in a child taking appetite-suppressant drugs. S Afr Med J 1982; 62:905-906. 34) Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37. 35) Liggett SB: Propylhexedrine intoxication: clinical presentation and pharmacology. South Med J 1982; 75:250-251. 36) Marsden P & Sheldon J: Acute poisoning by propylhexedrine. Br Med J 1972; 1:730. 37) McIntyre D: Psychosis due to nasal decongestant abuse. Br J Psychiatry 1976; 129:93-94. 38) Midha KK, Beckett AH, & Saunders A: Identification of the major metabolites of propylhexedrine in vivo (in man) and in vitro (in guinea pig and rabbit). Xenobiotica 1974; 4:627-635. 39) NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07. 40) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328. 41) Neumar RW , Otto CW , Link MS , et al: Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122(18 Suppl 3):S729-S767. 42) None Listed: Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42(3):243-253. 43) Pallis DJ & Barraclough BM: Psychosis and nasal decongestants. Practitioner 1972; 209:676. 44) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022. 45) Perez J, Burton BT, & McGirr J: Airway compromise and delayed death following attempted central vein injection of prophylhexedrine (Abstract). Vet Hum Toxicol 1991; 33:388. 46) Pollack MM, Dunbar BS, & Holbrook PR: Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10:528-529. 47) Product Information: BENZEDREX nasal inhaler, propylhexedrine nasal inhaler. B.F. Ascher & Co., Inc. (per Manufacturer), Lenexa, KS, 2014. 48) Product Information: BREVIBLOC(TM) intravenous injection, esmolol HCl intravenous injection. Baxter Healthcare Corporation (per FDA), Deerfield, IL, 2012. 49) Product Information: Benzedrex(R) Inhaler, propylhexedrine. SmithKline Consumer, Philadelphia, PA, 1990. 50) RTECS : Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2000; provided by Truven Health Analytics Inc., Greenwood Village, CO. 51) Rau NR, Nagaraj MV, Prakash PS, et al: Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297:918-919. 52) Raudonat HW & Schmidt K: (Sudden death in a drug milieu following use of an appetite suppressant). Plotzlicher Tod im Drogenmilieu nach Konsum eines Appetitzuglers. Beitr Gerichtl Med 1989; 47:539-540. 53) Riddick L & Reisch R: Oral overdose of propylhexedrine. J Forensic Sci 1981; 26:834-839. 54) Robertson CH Jr, Reynolds RC, & Wilson JE: Pulmonary hypertension and foreign body granulomas in intravenous drug abusers: documentation by cardiac catheterization and lung biopsy. Am J Med 1976; 61:657-664. 55) Smith DE, Wesson DR, & Sees KL: An epidemiological and clinical analysis of propylhexedrine abuse in the United States. J Psychoactive Drugs 1988; 20:441-442. 56) Spiller HA & Rogers GC: Evaluation of administration of activated charcoal in the home. Pediatrics 2002; 108:E100. 57) Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011. 58) Sturner WQ, Spruill FG, & Garriott JC: Two prophylhexedrine-associated fatalities: Benzedrine(R) revisited. J Forensic Sci 1974; 19:572-574. 59) Thakore S & Murphy N: The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19:63-65. 60) Vale JA, Kulig K, American Academy of Clinical Toxicology, et al: Position paper: Gastric lavage. J Toxicol Clin Toxicol 2004; 42:933-943. 61) Vale JA: Position Statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711-719. 62) Wesson DR: Propylhexdrine. Drug Alcohol Depend 1986; 17:273-278. 63) White L & DiMaio VJM: Intravenous propylhexedrine and sudden death. N Engl J Med 1977; 297:1071. 64) Willson DF, Truwit JD, Conaway MR, et al: The adult calfactant in acute respiratory distress syndrome (CARDS) trial. Chest 2015; 148(2):356-364. 65) Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.
|